Riehle J Nick 4
4 · Chelsea Therapeutics International, Ltd. · Filed Jan 26, 2009
Insider Transaction Report
Form 4
Riehle J Nick
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2009-01-22+50,000→ 50,000 totalExercise: $1.78Exp: 2019-01-22→ Common Stock (50,000 underlying)
Holdings
- 50,000
Stock Option (Right to Buy)
Exercise: $5.68Exp: 2017-02-06→ Common Stock (50,000 underlying) - 50,000
Stock Option (Right to Buy)
Exercise: $6.50Exp: 2018-01-24→ Common Stock (50,000 underlying) - 68,923
Stock Option (Right to Buy)
Exercise: $2.62Exp: 2015-01-10→ Common Stock (68,923 underlying) - 60,683
Common Stock
- 50,000
Stock Option (Right to Buy)
Exercise: $3.26Exp: 2016-01-19→ Common Stock (50,000 underlying)
Footnotes (5)
- [F1]Option vests in four equal annual installments beginning on January 22, 2010.
- [F2]Option vests in four equal annual installments beginning on January 24, 2009.
- [F3]Option vests in four equal annual installments beginning on February 6, 2008.
- [F4]Option vests in four equal annual installments beginning on January 19, 2007.
- [F5]Option vested in two equal annual installments beginning on January 10, 2006.